Characteristics | HIV-1 (n = 65) |
---|---|
Male [No (%)] | 34 (52.3%) |
Female [No (%)] | 31 (47.7%) |
Age, years [median (IQR:)] | 4.9 (2.2 – 9.1) |
Age distribution [No. (%)] | Â |
 < 2 years | 15 (23.1%) |
 2 – 4 years | 19 (29.2%) |
 ≥ 5 years | 31 (47.7%) |
Parent status [No. (%)] | Â |
Both parents alive | 34 (53.3%) |
Only mother living | 6 (9.2%) |
Only father living | 16 (24.6%) |
Both parents dead | 5 (7.7%) |
Unknown | 4 (6.2%) |
WHO Paediatric Clinical stage [No. (%)] | Â |
 Stage 1 | 26 (40.6%) |
 Stage 2 | 12 (18.5%) |
 Stage 3 | 19 (29.2%) |
 Stage 4 | 8 (12.3%) |
Immunologic category (CD4+%) [No. (%)] | Â |
 >25% | 1 (1.6%) |
 15% – 25% | 25 (39.7%) |
 <15% | 37 (58.7%) |
Baseline CD4+% [median (IQR); n = 63 a] | 13 (7 – 16) |
 < 2 years (n = 14) | 13 (6 – 16) |
 2 – 4 years (n = 18) | 14.5 (11 – 18) |
 ≥ 5 years (n = 31) | 10 (7 – 15) |
Baseline CD4+ count [median (IQR); n = 62 b] | 390 (210 – 730) |
 < 2 years (n = 13) | 510 (300 – 1100) |
 2 – 4 years (n = 18) | 615 (280 – 1020) |
 ≥ 5 years (n = 31) | 285 (100 – 520) |
Baseline Viral load, log10copies/mL [median (IQR); n = 55c] | 5.4 (4.5 – 6.0) |